1. Home
  2. CTMX vs DEA Comparison

CTMX vs DEA Comparison

Compare CTMX & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.77

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Logo Easterly Government Properties Inc.

DEA

Easterly Government Properties Inc.

HOLD

Current Price

$23.02

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
DEA
Founded
2008
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
977.1M
1.0B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
CTMX
DEA
Price
$3.77
$23.02
Analyst Decision
Strong Buy
Hold
Analyst Count
10
5
Target Price
$12.10
$23.49
AVG Volume (30 Days)
3.1M
297.1K
Earning Date
05-08-2026
04-27-2026
Dividend Yield
N/A
7.77%
EPS Growth
N/A
50.00
EPS
N/A
0.02
Revenue
$76,201,000.00
$336,099,000.00
Revenue This Year
N/A
$5.41
Revenue Next Year
$7.61
$3.33
P/E Ratio
$22.58
$1,146.50
Revenue Growth
N/A
11.27
52 Week Low
$1.72
$20.56
52 Week High
$8.21
$24.94

Technical Indicators

Market Signals
Indicator
CTMX
DEA
Relative Strength Index (RSI) 34.05 49.24
Support Level $3.76 $20.89
Resistance Level $3.91 $23.91
Average True Range (ATR) 0.22 0.51
MACD -0.03 -0.08
Stochastic Oscillator 9.87 23.93

Price Performance

Historical Comparison
CTMX
DEA

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About DEA Easterly Government Properties Inc.

Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: